New case study shows CAR T therapy as viable option for AML patients – News-Medical.net
News-Medical.net |
New case study shows CAR T therapy as viable option for AML patients
News-Medical.net Chimeric Antigen Receptor T–cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient's own immune cells to fight cancer … |
